# Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser

> **NCT07718347** · NA · RECRUITING · sponsor: **Lynch Regenerative Medicine** · enrollment: 21 (estimated)

## Conditions studied

- Immediate Post-Treatment Care
- Aging Mid-Face
- Aging

## Interventions

- **OTHER:** ariessence pure PDGF+™ is a sterile aqueous formulation containing Hyaluronic Acid and pure platelet-derived growth factor (PDGF).

## Key facts

- **NCT ID:** NCT07718347
- **Lead sponsor:** Lynch Regenerative Medicine
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-16
- **Primary completion:** 2026-11
- **Final completion:** 2027-02
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07718347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07718347, "Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07718347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*